To deal with a worrying fifth wave, the government has broadened the eligibility criteria for the vaccine booster, starting this Saturday.
PCR test valid for only 24 hours, wearing a mask again compulsory outdoors, vaccination for 5-11 year olds… The Minister of Health Olivier Véran unveiled on Thursday November 25 several measures to fight against the upsurge in Covid-19 cases in France. Among them is the possibility for all French adults to benefit from a booster dose of the vaccine as of today.
Who is eligible?
Until this Saturday, only those over 65 and the most fragile people could benefit from a booster dose of the Covid-19 vaccine. The booster dose is now available for the entire population.
Anyone over the age of 18 can receive it as early as five months after the last injection of Pfizer-BioNTech, Moderna or AstraZeneca vaccine and four weeks after the single injection of Janssen.
Is the health pass still valid?
Those over 65 must have received their booster dose by December 15, 2021 to be able to keep their health pass. For 18-64 year olds, the vaccination booster will be necessary from January 15, 2022.
If the booster dose is possible from five months, the health pass will not be deactivated until seven months after the primary vaccination. When it gets closer to its expiration date, an alert will appear on the TousAntiCovid application. Users will then be able to know the number of days remaining before deactivation.
For the unvaccinated, only PCR and antigen tests of less than 24 hours – and no longer 72 hours – will be proof for a temporary health pass.
Which vaccine to choose?
At this time, only messenger RNA vaccines, Pfizer and Moderna, can be given for the booster dose. Chosen for their effectiveness, they also have a lower rate of side effects compared to vaccines from Janssen and AstraZeneca laboratories.
It is also possible to be vaccinated in a pharmacy, by your attending physician, in a nursing or midwife’s office, by physiotherapists or even in vaccination centers.
Finally, a fourth dose of the vaccine will be available for severely immunocompromised people who have already received three doses and on medical advice.